Status:
UNKNOWN
CTO Registry From Insight of IVUS in Fuwai Hospital
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
Coronary Heart Disease
Chronic Total Occlusion of Coronary Artery
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the long-term outcome of chronic total occlusion (CTO) patients underwent contemporary percutaneous coronary intervention (PCI) techniques, we design this single-center, large-sample, pros...
Detailed Description
The study plan to include the patients with a CTO lesion in one of the three main epicardial coronary artery (diameter more than 2.5 mm) as the only target lesion. The CTO lesion is defined as 0 grade...
Eligibility Criteria
Inclusion
- Male or female patient \>18 years old
- Thrombolysis in myocardial infarction trial (TIMI) 0 grade.
- Evidence of occlusion period more than 3 months.
- Patients eligible for PCI.
- Patients eligible for coronary artery bypass graft (CABG).
- Target vessel is one of the three main epicardial coronary arteries.
Exclusion
- Acute myocardial infarction with ongoing ST-elevation
- Target vessel is left main or graft vessel.
- Target vessel diameter \< 2.5 mm.
- Other situations ineligible for PCI judged in clinical practice.
- Left ventricular ejection fraction \<30%
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT03461367
Start Date
January 1 2018
End Date
December 31 2025
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lei Song
Beijing, Beijing Municipality, China, 100037